APO RESEARCH · REPORT
Epidermal Growth Factor (EGF)
Epidermal Growth Factor (EGF) (CAS 62253-63-8) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.
Product & engineering
Understand the product.
Epidermal Growth Factor (EGF) (CAS 62253-63-8) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.
EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.
And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.
Selected research
Market Analysis & Forecast
Global Epidermal Growth Factor (EGF) Market Analysis and Forecast 2026-2032
Market perspective
Epidermal Growth Factor (EGF) (CAS 62253-63-8) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.
EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.
And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.
Read the full market overview
Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) key players include Pavay, Radiant Inc., BIO-FDandC Co.,Ltd, LipoTrue, S.L, BIOEFFECT, etc. Global top five players hold a share about 85%.
China is the largest market, with a share about 55%, followed by North America and Europe, having a total share about 25 percent.
In terms of product, Liquid is the largest segment, with a share about 75%. And in terms of application, the largest application is EGF Cream, followed by EGF Lotion, EGF Mask, etc.
This report presents an overview of global market for Epidermal Growth Factor (EGF), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Epidermal Growth Factor (EGF), also provides the sales of main regions and countries. Of the upcoming market potential for Epidermal Growth Factor (EGF), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Epidermal Growth Factor (EGF) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epidermal Growth Factor (EGF) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Epidermal Growth Factor (EGF) sales, projected growth trends, production technology, application and end-user industry.
Epidermal Growth Factor (EGF) Segment by Company
Pavay
Radiant
BIO-FDandC
LipoTrue
BIOEFFECT
Epidermal Growth Factor (EGF) Segment by Type
Liquid
Powder
Epidermal Growth Factor (EGF) Segment by Application
EGF Cream
EGF Lotion
EGF Mask
Other
Epidermal Growth Factor (EGF) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epidermal Growth Factor (EGF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epidermal Growth Factor (EGF) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epidermal Growth Factor (EGF).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Epidermal Growth Factor (EGF) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Epidermal Growth Factor (EGF) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epidermal Growth Factor (EGF) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
Applications
- EGF Cream
- EGF Lotion
- EGF Mask
- Other
Companies covered
- Pavay
- Radiant
- BIO-FDandC
- LipoTrue
- BIOEFFECT
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Epidermal Growth Factor (EGF) Market by Type
- 1.2.1 Global Epidermal Growth Factor (EGF) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Liquid
- 1.2.3 Powder
- 1.3 Epidermal Growth Factor (EGF) Market by Application
- 1.3.1 Global Epidermal Growth Factor (EGF) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 EGF Cream
- 1.3.3 EGF Lotion
- 1.3.4 EGF Mask
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Epidermal Growth Factor (EGF) Market Dynamics
- 2.1 Epidermal Growth Factor (EGF) Industry Trends
- 2.2 Epidermal Growth Factor (EGF) Industry Drivers
- 2.3 Epidermal Growth Factor (EGF) Industry Opportunities and Challenges
- 2.4 Epidermal Growth Factor (EGF) Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Epidermal Growth Factor (EGF) Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Epidermal Growth Factor (EGF) Revenue by Region
- 3.2.1 Global Epidermal Growth Factor (EGF) Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Epidermal Growth Factor (EGF) Revenue by Region (2021-2026)
- 3.2.3 Global Epidermal Growth Factor (EGF) Revenue by Region (2027-2032)
- 3.2.4 Global Epidermal Growth Factor (EGF) Revenue Market Share by Region (2021-2032)
- 3.3 Global Epidermal Growth Factor (EGF) Sales Estimates and Forecasts 2021-2032
- 3.4 Global Epidermal Growth Factor (EGF) Sales by Region
- 3.4.1 Global Epidermal Growth Factor (EGF) Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Epidermal Growth Factor (EGF) Sales by Region (2021-2026)
- 3.4.3 Global Epidermal Growth Factor (EGF) Sales by Region (2027-2032)
- 3.4.4 Global Epidermal Growth Factor (EGF) Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Epidermal Growth Factor (EGF) Revenue by Manufacturers
- 4.1.1 Global Epidermal Growth Factor (EGF) Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Epidermal Growth Factor (EGF) Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Epidermal Growth Factor (EGF) Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Epidermal Growth Factor (EGF) Sales by Manufacturers
- 4.2.1 Global Epidermal Growth Factor (EGF) Sales by Manufacturers (2021-2026)
- 4.2.2 Global Epidermal Growth Factor (EGF) Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Epidermal Growth Factor (EGF) Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Epidermal Growth Factor (EGF) Sales Price by Manufacturers (2021-2026)
- 4.4 Global Epidermal Growth Factor (EGF) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Epidermal Growth Factor (EGF) Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Epidermal Growth Factor (EGF) Manufacturers, Product Type & Application
- 4.7 Global Epidermal Growth Factor (EGF) Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Epidermal Growth Factor (EGF) Market CR5 and HHI
- 4.8.2 2025 Epidermal Growth Factor (EGF) Tier 1, Tier 2, and Tier 3
5 Epidermal Growth Factor (EGF) Market by Type
- 5.1 Global Epidermal Growth Factor (EGF) Revenue by Type
- 5.1.1 Global Epidermal Growth Factor (EGF) Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Epidermal Growth Factor (EGF) Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Epidermal Growth Factor (EGF) Revenue Market Share by Type (2021-2032)
- 5.2 Global Epidermal Growth Factor (EGF) Sales by Type
- 5.2.1 Global Epidermal Growth Factor (EGF) Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Epidermal Growth Factor (EGF) Sales by Type (2021-2032) & (g)
- 5.2.3 Global Epidermal Growth Factor (EGF) Sales Market Share by Type (2021-2032)
- 5.3 Global Epidermal Growth Factor (EGF) Price by Type
6 Epidermal Growth Factor (EGF) Market by Application
- 6.1 Global Epidermal Growth Factor (EGF) Revenue by Application
- 6.1.1 Global Epidermal Growth Factor (EGF) Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Epidermal Growth Factor (EGF) Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Epidermal Growth Factor (EGF) Revenue Market Share by Application (2021-2032)
- 6.2 Global Epidermal Growth Factor (EGF) Sales by Application
- 6.2.1 Global Epidermal Growth Factor (EGF) Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Epidermal Growth Factor (EGF) Sales by Application (2021-2032) & (g)
- 6.2.3 Global Epidermal Growth Factor (EGF) Sales Market Share by Application (2021-2032)
- 6.3 Global Epidermal Growth Factor (EGF) Price by Application
7 Company Profiles
- 7.1 Pavay
- 7.1.1 Pavay Company Information
- 7.1.2 Pavay Business Overview
- 7.1.3 Pavay Epidermal Growth Factor (EGF) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Pavay Epidermal Growth Factor (EGF) Product Portfolio
- 7.1.5 Pavay Recent Developments
- 7.2 Radiant
- 7.2.1 Radiant Company Information
- 7.2.2 Radiant Business Overview
- 7.2.3 Radiant Epidermal Growth Factor (EGF) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Radiant Epidermal Growth Factor (EGF) Product Portfolio
- 7.2.5 Radiant Recent Developments
- 7.3 BIO-FDandC
- 7.3.1 BIO-FDandC Company Information
- 7.3.2 BIO-FDandC Business Overview
- 7.3.3 BIO-FDandC Epidermal Growth Factor (EGF) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 BIO-FDandC Epidermal Growth Factor (EGF) Product Portfolio
- 7.3.5 BIO-FDandC Recent Developments
- 7.4 LipoTrue
- 7.4.1 LipoTrue Company Information
- 7.4.2 LipoTrue Business Overview
- 7.4.3 LipoTrue Epidermal Growth Factor (EGF) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 LipoTrue Epidermal Growth Factor (EGF) Product Portfolio
- 7.4.5 LipoTrue Recent Developments
- 7.5 BIOEFFECT
- 7.5.1 BIOEFFECT Company Information
- 7.5.2 BIOEFFECT Business Overview
- 7.5.3 BIOEFFECT Epidermal Growth Factor (EGF) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 BIOEFFECT Epidermal Growth Factor (EGF) Product Portfolio
- 7.5.5 BIOEFFECT Recent Developments
8 North America
- 8.1 North America Epidermal Growth Factor (EGF) Market Size by Type
- 8.1.1 North America Epidermal Growth Factor (EGF) Revenue by Type (2021-2032)
- 8.1.2 North America Epidermal Growth Factor (EGF) Sales by Type (2021-2032)
- 8.1.3 North America Epidermal Growth Factor (EGF) Price by Type (2021-2032)
- 8.2 North America Epidermal Growth Factor (EGF) Market Size by Application
- 8.2.1 North America Epidermal Growth Factor (EGF) Revenue by Application (2021-2032)
- 8.2.2 North America Epidermal Growth Factor (EGF) Sales by Application (2021-2032)
- 8.2.3 North America Epidermal Growth Factor (EGF) Price by Application (2021-2032)
- 8.3 North America Epidermal Growth Factor (EGF) Market Size by Country
- 8.3.1 North America Epidermal Growth Factor (EGF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Epidermal Growth Factor (EGF) Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Epidermal Growth Factor (EGF) Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Epidermal Growth Factor (EGF) Market Size by Type
- 9.1.1 Europe Epidermal Growth Factor (EGF) Revenue by Type (2021-2032)
- 9.1.2 Europe Epidermal Growth Factor (EGF) Sales by Type (2021-2032)
- 9.1.3 Europe Epidermal Growth Factor (EGF) Price by Type (2021-2032)
- 9.2 Europe Epidermal Growth Factor (EGF) Market Size by Application
- 9.2.1 Europe Epidermal Growth Factor (EGF) Revenue by Application (2021-2032)
- 9.2.2 Europe Epidermal Growth Factor (EGF) Sales by Application (2021-2032)
- 9.2.3 Europe Epidermal Growth Factor (EGF) Price by Application (2021-2032)
- 9.3 Europe Epidermal Growth Factor (EGF) Market Size by Country
- 9.3.1 Europe Epidermal Growth Factor (EGF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Epidermal Growth Factor (EGF) Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Epidermal Growth Factor (EGF) Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Epidermal Growth Factor (EGF) Market Size by Type
- 10.1.1 China Epidermal Growth Factor (EGF) Revenue by Type (2021-2032)
- 10.1.2 China Epidermal Growth Factor (EGF) Sales by Type (2021-2032)
- 10.1.3 China Epidermal Growth Factor (EGF) Price by Type (2021-2032)
- 10.2 China Epidermal Growth Factor (EGF) Market Size by Application
- 10.2.1 China Epidermal Growth Factor (EGF) Revenue by Application (2021-2032)
- 10.2.2 China Epidermal Growth Factor (EGF) Sales by Application (2021-2032)
- 10.2.3 China Epidermal Growth Factor (EGF) Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Epidermal Growth Factor (EGF) Market Size by Type
- 11.1.1 Asia Epidermal Growth Factor (EGF) Revenue by Type (2021-2032)
- 11.1.2 Asia Epidermal Growth Factor (EGF) Sales by Type (2021-2032)
- 11.1.3 Asia Epidermal Growth Factor (EGF) Price by Type (2021-2032)
- 11.2 Asia Epidermal Growth Factor (EGF) Market Size by Application
- 11.2.1 Asia Epidermal Growth Factor (EGF) Revenue by Application (2021-2032)
- 11.2.2 Asia Epidermal Growth Factor (EGF) Sales by Application (2021-2032)
- 11.2.3 Asia Epidermal Growth Factor (EGF) Price by Application (2021-2032)
- 11.3 Asia Epidermal Growth Factor (EGF) Market Size by Country
- 11.3.1 Asia Epidermal Growth Factor (EGF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Epidermal Growth Factor (EGF) Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Epidermal Growth Factor (EGF) Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Epidermal Growth Factor (EGF) Market Size by Type
- 12.1.1 SAMEA Epidermal Growth Factor (EGF) Revenue by Type (2021-2032)
- 12.1.2 SAMEA Epidermal Growth Factor (EGF) Sales by Type (2021-2032)
- 12.1.3 SAMEA Epidermal Growth Factor (EGF) Price by Type (2021-2032)
- 12.2 SAMEA Epidermal Growth Factor (EGF) Market Size by Application
- 12.2.1 SAMEA Epidermal Growth Factor (EGF) Revenue by Application (2021-2032)
- 12.2.2 SAMEA Epidermal Growth Factor (EGF) Sales by Application (2021-2032)
- 12.2.3 SAMEA Epidermal Growth Factor (EGF) Price by Application (2021-2032)
- 12.3 SAMEA Epidermal Growth Factor (EGF) Market Size by Country
- 12.3.1 SAMEA Epidermal Growth Factor (EGF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Epidermal Growth Factor (EGF) Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Epidermal Growth Factor (EGF) Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Epidermal Growth Factor (EGF) Value Chain Analysis
- 13.1.1 Epidermal Growth Factor (EGF) Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Epidermal Growth Factor (EGF) Production Mode & Process
- 13.2 Epidermal Growth Factor (EGF) Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Epidermal Growth Factor (EGF) Distributors
- 13.2.3 Epidermal Growth Factor (EGF) Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst